Mammalian Non-CpG Methylation: Stem Cells and Beyond.

Area of Science:

• Epigenetics
• Molecular Biology
• Genomics

Background:

• DNA methylation traditionally occurs at CpG sites in mammals.
• Non-CpG methylation (CpA, CpT, CpC) is abundant in plants and embryonic stem cells.
• Previously, non-CpG methylation was thought to be lost during mammalian cell differentiation.

Purpose of the Study:

• To investigate the presence and role of non-CpG methylation in adult mammalian somatic cells.
• To explore the relationship between non-CpG methylation and gene expression.
• To highlight the potential contribution of non-CpG methylation alterations to human diseases.

Main Methods:

• Genome-wide assays to measure non-CpG methylation.
• High-throughput sequencing techniques.
• RNA-Sequencing to correlate methylation with gene expression.

Main Results:

• Non-CpG methylation is negligible in human fetal brain but abundant in adult brain.
• In the adult human brain, non-CpG methylation levels are inversely proportional to mRNA transcript abundance.
• Specific genes (PGC1α, IFN-γ, SYT11) show altered non-CpG methylation linked to gene expression changes and disease.

Conclusions:

• Non-CpG methylation is a significant epigenetic modification in adult mammalian somatic cells, particularly the brain.
• Non-CpG methylation actively regulates gene expression, influencing cellular function.
• Dysregulation of non-CpG methylation is implicated in the pathogenesis of human diseases.